Dermatology and Therapy (Sep 2023)

Letter to the Editor: Response to Fitzgerald T et al. Long-Term Psoriasis Control with Guselkumab, Adalimumab, Secukinumab, or Ixekizumab in the USA

  • Andrew Blauvelt,
  • Alyssa Garrelts,
  • William Malatestinic,
  • Julie Birt,
  • Baojin Zhu,
  • Meghan Feely

DOI
https://doi.org/10.1007/s13555-023-01015-w
Journal volume & issue
Vol. 13, no. 11
pp. 2911 – 2916

Abstract

Read online

No abstracts available.

Keywords